Valuation : Sysmex Corporation

Market Cap 1,188B 7.43B 6.4B 6B 5.48B 10.32B 710B 10.35B 71.18B 27.77B 358B 27.88B 27.28B P/E 2027 *
29.9x
P/E 2028 * 23.5x
Enterprise Value 1,210B 7.56B 6.52B 6.11B 5.58B 10.51B 723B 10.54B 72.49B 28.28B 365B 28.4B 27.78B EV / Sales 2027 *
2.22x
EV / Sales 2028 * 2.11x
Free-Float
72.3%
Yield 2027 *
2.07%
Yield 2028 * 2.1%
1 day+0.41%
1 week-0.68%
Current month+22.76%
1 month+17.54%
3 months+40.52%
6 months+33.13%
Current year+27.26%
1 week 1,912.5
Extreme 1912.5
2,012.5
1 month 1,553
Extreme 1553
2,012.5
Current year 1,246
Extreme 1246
2,012.5
1 year 1,246
Extreme 1246
2,012.5
3 years 1,246
Extreme 1246
3,236
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 76 2018-03-31
Director of Finance/CFO 56 -
President 65 2026-03-31
Director TitleAgeSince
Chairman 76 2013-03-31
Director/Board Member 65 2019-05-31
Director/Board Member 71 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.41%-0.68%+5.09%-23.67% 7.4B
-2.52%-5.73%-16.34%+6.88% 195B
-0.49%-2.19%-2.64%+11.50% 117B
+0.45%+0.29%+10.13%+84.52% 61.45B
-0.63%-1.10%+0.27%-32.49% 51.62B
+0.80%-1.18%+27.79%+52.56% 51.03B
-0.76%-0.94%+21.41%-10.67% 34.27B
-0.30%+1.44% - - 30.95B
+1.08%-3.63%+39.69%-16.32% 23.75B
-0.91%-2.06%-5.54%+16.29% 23.41B
Average -0.27%-1.32%+8.87%+9.84% 59.53B
Weighted average by Cap. -0.89%-1.94%+0.27%+14.77%

Financials

2027 *2028 *
Net sales 545B 3.41B 2.93B 2.75B 2.51B 4.73B 326B 4.75B 32.65B 12.74B 164B 12.79B 12.51B 572B 3.57B 3.08B 2.89B 2.64B 4.96B 341B 4.98B 34.25B 13.36B 172B 13.41B 13.12B
Net income 40.72B 255M 219M 206M 188M 354M 24.33B 355M 2.44B 952M 12.28B 956M 935M 50.9B 318M 274M 257M 235M 442M 30.41B 443M 3.05B 1.19B 15.35B 1.19B 1.17B
Net Debt 21.85B 137M 118M 110M 101M 190M 13.05B 190M 1.31B 511M 6.59B 513M 502M 20.67B 129M 111M 104M 95.32M 180M 12.35B 180M 1.24B 483M 6.24B 485M 475M
Logo Sysmex Corporation
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Employees
10,861
Date Price Change Volume
26-08-31 ¥1,963.00 +0.41% 2,624,400
26-08-28 ¥1,955.00 +1.82% 2,101,100
26-08-27 ¥1,920.00 -1.03% 1,918,500
26-08-26 ¥1,940.00 -1.55% 2,282,000
26-08-25 ¥1,970.50 +0.92% 2,646,000
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,963.00JPY
Average target price
1,989.29JPY
Spread / Average Target
+1.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6869 Stock